What are the contraindications for Vancomycin (vancomycin hydrochloride)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2025 • View editorial policy

There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.

From the FDA Drug Label

  • Contraindications: The FDA drug label states that vancomycin hydrochloride for injection is contraindicated in patients with: + Known hypersensitivity to this antibiotic 1
  • No other direct contraindications are mentioned in the provided drug labels.

From the Research

Contraindications for Vancomycin

The following are contraindications for vancomycin:

  • Hypersensitivity to vancomycin 2, 3
  • Renal impairment or nephrotoxicity, as vancomycin can cause nephrotoxicity, especially at higher doses or with prolonged therapy 2, 4, 3, 5
  • Ototoxicity, as vancomycin can cause hearing loss, especially in patients with renal impairment 2, 3, 5
  • Red man syndrome, a hypersensitivity reaction that can occur with vancomycin administration 2, 3
  • Neutropenia, as vancomycin can cause bone marrow suppression 2
  • Interstitial nephritis, as vancomycin can cause inflammation of the kidneys 2

Special Considerations

  • Vancomycin should be used with caution in patients with:
    • Hepatic dysfunction, as vancomycin can cause liver damage 5
    • Hypertension or diabetes, as these conditions can increase the risk of side effects 5
    • Prolonged therapy, as this can increase the risk of nephrotoxicity and other side effects 2, 4, 3, 5
  • Vancomycin should not be used alone in enterococcal endocarditis, as it is not effective against these organisms 6

References

Research

The use of vancomycin with its therapeutic and adverse effects: a review.

European review for medical and pharmacological sciences, 2015

Research

Vancomycin revisited - 60 years later.

Frontiers in public health, 2014

Research

Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice.

Clinical and experimental pharmacology & physiology, 2019

Research

Vancomycin.

Mayo Clinic proceedings, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.